-transparent.png){kind=logo}
Neonatal hyperthyroidism has been thought to result from transplacental passage of long-acting thyroid stimulator (L.A.T.S.) from a mother with Graves's disease. A case is presented here in which no L.A.T.S. was detected in the mother or neonate but another immunoglobulin, L.A.T.S. protector, a specific human thyroid stimulator, was shown to be present in the mother's serum. This stimulator may have been the cause of the neonatal hyperthyroidism.
Related Publications
J Nutt, and
F Clark, and
R G Welch, and
R Hall
April 1975,
British medical journal,
J Nutt, and
F Clark, and
R G Welch, and
R Hall
March 1977,
Irish medical journal,
J Nutt, and
F Clark, and
R G Welch, and
R Hall
March 1975,
The Journal of endocrinology,
J Nutt, and
F Clark, and
R G Welch, and
R Hall
June 1981,
Clinical endocrinology,
J Nutt, and
F Clark, and
R G Welch, and
R Hall
February 1979,
The Journal of endocrinology,
J Nutt, and
F Clark, and
R G Welch, and
R Hall
May 1967,
Schweizerische medizinische Wochenschrift,
J Nutt, and
F Clark, and
R G Welch, and
R Hall
November 1969,
Danish medical bulletin,
J Nutt, and
F Clark, and
R G Welch, and
R Hall
March 1983,
British medical journal (Clinical research ed.),
J Nutt, and
F Clark, and
R G Welch, and
R Hall
April 1974,
British medical journal,
J Nutt, and
F Clark, and
R G Welch, and
R Hall
October 1969,
Klinicheskaia meditsina,
